ARCHIVES

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve New Grant Program In Bone Metastasis

April 5, 2002

In Brief: Tipping Resigns Forom ACS; Vaughan Joins UAB BMT Program; PCI Recruits Ball, Finn, Mirro

September 20, 1991

In Brief: Krakoff To Head New M.D. Anderson Division, Two Other Appointments Made In Reorganization There

July 22, 1983

Prostate Cancer Patient Groups Consider formation Of Coalition Using the “NBCC Model”

August 16, 1996

Funding Opportunities.

June 28, 2002

Watson Steps Down As Chancellor at Cold Spring Harbor Laboratory.

October 26, 2007